INOVA PHARMACEUTICALS

iNova to buy Mundipharma's consumer healthcare brands for $540 mln

The deal will significantly expand iNova's portfolio of consumer health products and add substantial new sales in high-growth markets, said the spokesperson. The transaction will give iNova, which markets and sells a wide range of over-the-counter drugs and consumer healthcare products, greater exposure in Asia, especially in Japan and Indonesia.